Eric Gornstein Email

SVP BD & Cell Therapy Partnerships . Bit Bio

Cambridge, MA

Location

e***@bit.bio

Primary Email

Current Roles

Employees:
249
Revenue:
$38.6M
About
Bit Bio is an award-winning human synthetic biology enterprise. Our mission is to code cells to advance the wellbeing of humanity. To do so, we apply the principles of computation to biology. Our current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. This has the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by human disease. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies. To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modelling, and cell therapy. Collaboration is at the heart of Bit Bio. We are empirical, highly ambitious and driven by a common purpose.
Bit Bio Address
The Dorothy Hodgkin Building
Cambridge, MA
UK
Bit Bio Email

Past Companies

bit.bioSenior Vice President BD & Cell Therapy Partnerships
Talaris TherapeuticsSenior Vice President, Strategy
Talaris TherapeuticsVice President, Strategy

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.